Xtandi
/
Xtandi (enzalutamide) is an androgen receptor inhibitor indicated for the treatment of metastatic castration-resistant prostate cancer. It is administered as an oral tablet and is available by prescription only. Patients are advised that Xtandi may cause seizures and should not be used in patients with a history of seizures or conditions that may predispose them to seizures.
FAQs about Xtandi
What should I do if I miss a dose?
If you miss a dose of Xtandi, take it as soon as you remember on the same day. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not take two doses at the same time to make up for a missed dose. This information is provided in the Patient Counseling Information section of the label.
Can I take Xtandi while pregnant or breastfeeding?
Xtandi is not recommended for use during pregnancy as it may cause harm to a developing fetus. Women who are pregnant or may become pregnant should avoid handling the capsules. It is also advised that women do not breastfeed while taking Xtandi, as it is not known if enzalutamide is excreted in human milk. This information is found in the Warnings and Precautions section of the label.
Can I stop taking Xtandi suddenly?
Patients are advised not to stop taking Xtandi without consulting their healthcare provider. Abrupt discontinuation may lead to a worsening of the condition being treated. This caution is mentioned in the Warnings and Precautions section of the label.
How should I store Xtandi?
Xtandi should be stored at room temperature, between 20°C to 25°C (68°F to 77°F). It should be kept in its original container and protected from moisture. This storage information is provided in the Storage section of the label.
25
commonly-prescribed
medication.